- The report contains detailed information about Hansa Medical AB that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Hansa Medical AB. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Hansa Medical AB financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Hansa Medical AB competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Hansa Medical AB business.
About Hansa Medical AB
Hansa Medical AB operates as a biotechnology research and development company that focuses on the treatment and diagnosis of inflammation. It is developing two preclinical biopharmaceutical programs, including anti-alpha-11 for the treatment of rheumatoid arthritis; and IdeS for treatment in connection with organ transplantation. The company is also developing a clinical-stage diagnostic method, HMD-301, for the prognosis and diagnosis of severe sepsis. Hansa Medical AB has collaboration agreements with Axis-Shield plc to develop Heparin Binding Protein as a biomarker for severe sepsis; and Inverness Medical Innovations Inc. and Biosite Inc. to develop anti-alpha-11 antibodies. The company was founded in 2001 and is based in Lund, Sweden.
RESEARCH METHODOLOGY
DISCLAIMER
1. HANSA MEDICAL AB COMPANY PROFILE
1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. HANSA MEDICAL AB BUSINESS OVERVIEW
2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. HANSA MEDICAL AB SWOT ANALYSIS
3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats
4. HANSA MEDICAL AB FINANCIAL ANALYSIS
4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.1. Profitability
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. HANSA MEDICAL AB COMPETITORS AND INDUSTRY ANALYSIS
5.1. Hansa Medical AB Direct Competitors
5.2. Comparison of Hansa Medical AB and Direct Competitors Financial Ratios
5.3. Comparison of Hansa Medical AB and Direct Competitors Stock Charts
5.4. Hansa Medical AB Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
5.4.2. Hansa Medical AB Industry Position Analysis
6. HANSA MEDICAL AB NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. HANSA MEDICAL AB EXPERTS REVIEW*
7.1. Experts Opinion
7.2. Experts Estimates
APPENDIX 1: RATIO DEFINITIONS
LIST OF TABLES
Hansa Medical AB Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Hansa Medical AB Key Executives
Key Executives Biographies*
Key Executives Compensations*
Hansa Medical AB Major Shareholders
Hansa Medical AB History
Hansa Medical AB Products
Revenues by Product
Revenues by Region
Hansa Medical AB Offices and Representations
Hansa Medical AB SWOT Analysis
Income Statement 2009-2012 Including 4-years Trends
Income Statement Latest 4 Quarters Including Trends
Balance Sheet 2009-2012 Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Cash Flow 2009-2012 Including Trends
Cash Flow Latest 4 Quarters Including Trends
Hansa Medical AB Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Hansa Medical AB Capital Market Snapshot
Hansa Medical AB Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Hansa Medical AB Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Hansa Medical AB Consensus Recommendations*
Analyst Recommendation Summary*
Price Target Summary*
Experts Recommendation Trends*
Revenue Estimates Analysis*
Earnings Estimates Analysis*
Historical Surprises*
Revenue Estimates Trend*
Earnings Estimates Trend*
Revenue Revisions*
Earnings Revisions*
LIST OF FIGURES
Hansa Medical AB Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Hansa Medical AB 1-year Stock Charts
Hansa Medical AB 5-year Stock Charts
Hansa Medical AB vs. Main Indexes 1-year Stock Chart
Hansa Medical AB vs. Direct Competitors 1-year Stock Charts
Hansa Medical AB Article Density Chart
* – Data availability depends on company’s security policy.
The complete financial data is available for public traded companies.
The above Company Fundamental Report is a half-ready report.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price.
